دورية أكاديمية

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

التفاصيل البيبلوغرافية
العنوان: Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
المؤلفون: Riaz, Nadeem, Havel, Jonathan J., Makarov, Vladimir, Desrichard, Alexis, Urba, Walter J., Sims, Jennifer S., Hodi, F. Stephen, Martín-Algarra, Salvador, Mandal, Rajarsi, Sharfman, William H., Bhatia, Shailender, Hwu, Wen-Jen, Gajewski, Thomas F., Slingluff, Craig L., Chowell, Diego, Kendall, Sviatoslav M., Chang, Han, Shah, Rachna, Kuo, Fengshen, Morris, Luc G.T., Sidhom, John-William, Schneck, Jonathan P., Horak, Christine E., Weinhold, Nils, Chan, Timothy A.
المساهمون: Bristol-Myers Squibb, Pershing Square Sohn Cancer Research Foundation, PaineWebber Chair, Stand Up 2 Cancer, Memorial Sloan Kettering Cancer Center, STARR Cancer Consortium, Abraxis, Amgen, Bionomics, EMD Serono, Immune Design, Immunogen, Merck, NantKwest, OncoSec, Incyte, Ono, Genentech, Seattle Genetics, GlaxoSmithKline, MedImmune, NexImmune, Polynoma
المصدر: Cell ; volume 171, issue 4, page 934-949.e16 ; ISSN 0092-8674
بيانات النشر: Elsevier BV
سنة النشر: 2017
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.cell.2017.09.028
الإتاحة: https://doi.org/10.1016/j.cell.2017.09.028Test
https://api.elsevier.com/content/article/PII:S0092867417311224?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0092867417311224?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/
رقم الانضمام: edsbas.85DCC2D1
قاعدة البيانات: BASE